22
Participants
Start Date
June 11, 2024
Primary Completion Date
March 15, 2025
Study Completion Date
June 15, 2025
Intralesional injection of Candida albicans 1:20 w/v 10 ml vial (Allergy Laboratories, INC. Oklahoma City, USA.)
Intralesional injection of 0.2 ml of 1/1000 solution of Candida albicans antigen using an insulin syringe directly into the warts; Candida albicans 1:20 w/v 10 ml vial (Allergy Laboratories, INC. Oklahoma City, USA.). The same injection was repeated every 2 weeks until complete clearance for a maximum of six treatment sessions.
Zagazig University, Zagazig
Zagazig University
OTHER_GOV